US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist

4.720
-0.250-5.03%

Close Oct 3 16:00 ET

267.25MMarket Cap-5244P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Design Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--
Mar 19, 2024	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Mar 19, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Design Therapeutics Earnings Reports

Design Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 5 08:17 ET

Design Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 16:55 ET

Design Therapeutics | 10-K: FY2023 Annual Report

Mar 19 16:23 ET

Design Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 13, 2023 16:14 ET

Analyst Rating

Updated: Oct 3, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall